These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 302531)

  • 21. Propagation and characterization of lymphocytes from transplant biopsies.
    Duquesnoy RJ; Trager JD; Zeevi A
    Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biology of the immunological tolerance (author's transl)].
    Katsura Y; Muramatsu S
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):939-48. PubMed ID: 4612621
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transplantation immunology: mechanism of rejection. Mode of action of immunosuppressive drugs].
    Kreis H
    Acta Chir Belg; 1987; 87(3):184-92. PubMed ID: 2956816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antilymphocyte serum. I].
    Bach JF
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):28-55. PubMed ID: 4393724
    [No Abstract]   [Full Text] [Related]  

  • 25. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 26. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of immunosuppressive agents on T and B lymphocytes.
    Thomas F; Owens L; Thomas J; Wolf JS; Volk M; Mendez G; Lee HM
    Proc Clin Dial Transplant Forum; 1974; (4):124-9. PubMed ID: 4619655
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 29. [Modification of the immune reaction by antigen-immunosuppressive-agent conjugates. I. Tentative hypothesis for the induction of antigen-specific suppression by antigen-immunosuppressive-agent conjugates].
    Ambrosius H
    Acta Biol Med Ger; 1976; 35(12):1677-85. PubMed ID: 69372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppression: building on Sandimmune (cyclosporine).
    Borel JF
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):149-53. PubMed ID: 2964748
    [No Abstract]   [Full Text] [Related]  

  • 31. Antilymphocytic serum. (A brief review of current concepts).
    Gupta RM; Gupta IM
    J Indian Med Assoc; 1979 Dec; 73(11):200-4. PubMed ID: 95021
    [No Abstract]   [Full Text] [Related]  

  • 32. [Perspectives of immunosuppressive therapy].
    Meuer S; Sido B; Dengler T
    Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
    Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
    Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Function of macrophage (author's transl)].
    Takeya K; Nomoto K
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):889-99. PubMed ID: 4612618
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of specific unresponsiveness to allogeneic tissue: an introduction.
    Thorsby E
    Proc Eur Dial Transplant Assoc; 1977; 14():239-44. PubMed ID: 304578
    [No Abstract]   [Full Text] [Related]  

  • 36. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological problems in organ transplantation (with reference to oncology)].
    Gazzera G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(9):599-614. PubMed ID: 4932115
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of ATG-induced experimental transplantation tolerance with LS2616.
    Olausson M; Arvidsson N; Lukes D; Mjörnstedt L; Qi Z; Ekberg H; Gannedahl G; Tufveson G
    Transplant Proc; 1995 Dec; 27(6):3541-3. PubMed ID: 8540092
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunobiological fundamentals of primary graft rejection (author's transl)].
    Prange CH; Kliems G
    Zentralbl Chir; 1978; 103(3):157-65. PubMed ID: 347835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological enhancement of muscle allografts induced by serum from tolerant rats.
    Gutmann E; Hasek M; Chutná J
    Folia Biol (Praha); 1978; 24(1):25-31. PubMed ID: 344077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.